Literature DB >> 16144195

Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment.

Emeran A Mayer1, Bruce D Naliboff, Lin Chang.   

Abstract

The physiological effects of psychological and physical stressors on gut function and brain-gut interactions are mediated by outputs of the emotional motor system in terms of autonomic, neuroendocrine, attentional, and pain modulatory responses. IBS patients with irritable bowel syndroms show an exaggerated responsiveness of this system manifesting itself in altered modulation of gastrointestinal motility and epithelial function, in alterations in the perception of visceral events, and in the associated conscious emotional responses. Animal models are being developed with high face and construct validity for functional visceral disorders that affect the gastrointestinal and urogenital tracts. These animal models suggest plausible targets for future drug development both in the periphery and in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 16144195

Source DB:  PubMed          Journal:  Eur J Surg Suppl        ISSN: 1102-416X


  8 in total

Review 1.  The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome.

Authors:  Lin Chang
Journal:  Gastroenterology       Date:  2011-01-19       Impact factor: 22.682

Review 2.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

3.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

4.  Predictors of patient-assessed illness severity in irritable bowel syndrome.

Authors:  Brennan Spiegel; Amy Strickland; Bruce D Naliboff; Emeran A Mayer; Lin Chang
Journal:  Am J Gastroenterol       Date:  2008-06-12       Impact factor: 10.864

5.  Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo.

Authors:  Zhonghan Yang; Viktoriya Grinchuk; Siu Po Ip; Chun-Tao Che; Harry H S Fong; Lixing Lao; Justin C Wu; Joseph J Sung; Brian Berman; Terez Shea-Donohue; Aiping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-22       Impact factor: 2.629

6.  The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study.

Authors:  Mark S Riddle; Marleen Welsh; Chad K Porter; Chiping Nieh; Edward J Boyko; Gary Gackstetter; Tomoko I Hooper
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

7.  P22 Phage Shows Promising Antibacterial Activity under Pathophysiological Conditions.

Authors:  Logan Gildea; Joseph A Ayariga; Boakai K Robertson; Robert Villafane
Journal:  Arch Microbiol Immunol       Date:  2022-02-10

Review 8.  Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.

Authors:  S W Tsang; K K W Auyeung; Z X Bian; J K S Ko
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.